BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3495295)

  • 1. The complement component C1s catalysed hydrolysis of peptide 4-nitroanilide substrates.
    Keogh SJ; Harding DR; Hardman MJ
    Biochim Biophys Acta; 1987 May; 913(1):39-44. PubMed ID: 3495295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates.
    Kam CM; McRae BJ; Harper JW; Niemann MA; Volanakis JE; Powers JC
    J Biol Chem; 1987 Mar; 262(8):3444-51. PubMed ID: 3546307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates.
    O'Brien G; Quinsey NS; Whisstock JC; Pike RN
    Biochemistry; 2003 Dec; 42(50):14939-45. PubMed ID: 14674770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of two proteinases that cleave adjacent to arginine, C1 esterase and acrosin, for peptide p-nitroanilide substrates.
    Skoog MT; Mehdi S; Wiseman JS; Bey P
    Biochim Biophys Acta; 1989 Jun; 996(1-2):89-94. PubMed ID: 2500154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1s, C1r2-C1s2 and C1.
    Thielens NM; Villiers MB; Reboul A; Villiers CL; Colomb MG
    FEBS Lett; 1982 May; 141(1):19-24. PubMed ID: 6282646
    [No Abstract]   [Full Text] [Related]  

  • 6. Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation.
    Spycher SE; Nick H; Rickli EE
    Eur J Biochem; 1986 Apr; 156(1):49-57. PubMed ID: 3007145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the fluid-phase proteolytic cleavage of human complement subcomponents C4 and C2 by C1s and C1r2-C1s2.
    Thielens NM; Villiers CL; Villiers MB; Colomb MG
    FEBS Lett; 1984 Jan; 165(1):111-6. PubMed ID: 6319179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
    Bauer J; Valet G
    Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and activity of C1r and C1s.
    Carter PE; Dunbar B; Fothergill JE
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):293-9. PubMed ID: 6149574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of the linker between the complement control protein modules of complement protease C1s.
    Bally I; Rossi V; Thielens NM; Gaboriaud C; Arlaud GJ
    J Immunol; 2005 Oct; 175(7):4536-42. PubMed ID: 16177097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and properties of human C1 inhibitor.
    Sim RB; Reboul A
    Methods Enzymol; 1981; 80 Pt C():43-54. PubMed ID: 6281621
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Croonian Lecture, 1980. The complex proteases of the complement system.
    Porter RR
    Proc R Soc Lond B Biol Sci; 1980 Nov; 210(1181):477-98. PubMed ID: 6110208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.
    Ghebrehiwet B; Randazzo BP; Dunn JT; Silverberg M; Kaplan AP
    J Clin Invest; 1983 May; 71(5):1450-6. PubMed ID: 6304147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-sensitive thermal transitions and domain structure of human complement subcomponent C1r.
    Busby TF; Ingham KC
    Biochemistry; 1987 Aug; 26(17):5564-71. PubMed ID: 2823884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary structure of the reactive site of human C1-inhibitor.
    Salvesen GS; Catanese JJ; Kress LF; Travis J
    J Biol Chem; 1985 Feb; 260(4):2432-6. PubMed ID: 3919001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
    Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
    Bianchino AC; Poon PH; Schumaker VN
    J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the substrate binding site of human C1r and C1s with peptide thioesters. Development of new sensitive substrates.
    McRae BJ; Lin TY; Powers JC
    J Biol Chem; 1981 Dec; 256(23):12362-6. PubMed ID: 6271784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.